Loading
Latest filing published 13 Nov 2009 for GTC BIOTHERAPEUTICS INC, €11k.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Daniel S. Woloshen is a declared insider of GTC Biotherapeutics Inc, with filings sourced from SEC (Form 4). Over a trading history stretching from 10 March 2006 to 2 November 2009, the count stands at 12 filings.
Market trades split into 1 purchase (€741) and 2 sales (€13k). Netting one side against the other leaves €12k of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 9 share grants.
On 13 November 2009 came the latest disclosure, a share grant for €3,429 in GTC Biotherapeutics Inc. The last purchase on record was published on 17 December 2007, which is 6,885 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations